AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 63 filers reported holding AKCEA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $179,000 | +29.7% | 9,840 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $138,000 | +29.0% | 10,062 | +35.0% | 0.00% | 0.0% |
| Q1 2020 | $107,000 | -20.1% | 7,453 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $134,000 | +10.7% | 7,882 | +0.4% | 0.00% | – |
| Q3 2019 | $121,000 | -34.6% | 7,853 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $185,000 | -22.9% | 7,908 | -6.7% | 0.00% | 0.0% |
| Q1 2019 | $240,000 | -5.1% | 8,480 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $253,000 | -14.5% | 8,396 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $296,000 | +50.3% | 8,460 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $197,000 | -19.9% | 8,307 | -13.4% | 0.00% | 0.0% |
| Q1 2018 | $246,000 | +40.6% | 9,588 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $175,000 | -36.4% | 10,102 | +1.7% | 0.00% | 0.0% |
| Q3 2017 | $275,000 | – | 9,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |